134 related articles for article (PubMed ID: 2517705)
1. Hormonal therapy in climacteric women: compliance and its socioeconomic impact.
Notelovitz M
Public Health Rep; 1989; 104 Suppl(Suppl):70-5. PubMed ID: 2517705
[TBL] [Abstract][Full Text] [Related]
2. Hormone replacement therapy among Danish women aged 45-65 years: prevalence, determinants, and compliance.
Oddens BJ; Boulet MJ
Obstet Gynecol; 1997 Aug; 90(2):269-77. PubMed ID: 9241307
[TBL] [Abstract][Full Text] [Related]
3. [Climacteric--medicalization, minimalization or normalization?].
Hovelius B; Ekström H; Esseveld J; Landgren BM; Vinge E
Lakartidningen; 2000 Dec; 97(50):5927-30. PubMed ID: 11188537
[TBL] [Abstract][Full Text] [Related]
4. [Hormone treatment in the climacteric].
Siegberg R; Pekonen F
Nord Med; 1993; 108(10):259-62. PubMed ID: 8414944
[TBL] [Abstract][Full Text] [Related]
5. [Hormone substitution in climacteric. Position of the German Menopause Society].
Schneider HP; Kuhl H; Dören M; Hesch D
Zentralbl Gynakol; 1995; 117(6):B1-4. PubMed ID: 7645352
[No Abstract] [Full Text] [Related]
6. [Hormone therapy in the climacteric of women].
Runnebaum B; von Holst T
Med Monatsschr Pharm; 1993 Feb; 16(2):43-7. PubMed ID: 8441360
[No Abstract] [Full Text] [Related]
7. [Estrogen therapy in climacteric. Current views in an evidence-based perspective].
Nilsson K
Lakartidningen; 2001 Jul; 98(28-29):3225-8. PubMed ID: 11496812
[TBL] [Abstract][Full Text] [Related]
8. Prognostic features of menopausal and postmenopausal applicants for life insurance.
Schiefeling M
J Insur Med; 1996; 28(1):27-34. PubMed ID: 10172866
[TBL] [Abstract][Full Text] [Related]
9. [Effect of long-term hormone substitution therapy on serum TSH level in postmenopausal women].
Foth D; Römer T
Zentralbl Gynakol; 1999; 121(10):495-8. PubMed ID: 10573824
[TBL] [Abstract][Full Text] [Related]
10. [Hormone substitution in menopause].
Keller PJ; Maurer-Major E
Praxis (Bern 1994); 1997 Sep; 86(38):1458-62. PubMed ID: 9381046
[TBL] [Abstract][Full Text] [Related]
11. Climacteric medicine: European Menopause and Andropause Society (EMAS) 2004/2005 position statements on peri- and postmenopausal hormone replacement therapy.
Skouby SO; Al-Azzawi F; Barlow D; Calaf-Alsina Erdogan Ertüngealp J; Gompel A; Graziottin A; Hudita D; Pines A; Rozenberg S; Samsioe G; Stevenson JC;
Maturitas; 2005 May; 51(1):8-14. PubMed ID: 15883103
[TBL] [Abstract][Full Text] [Related]
12. [Raloxifene in clinical practice. Results of the non-interventional study CORAL (COmpliance with RALoxifene)].
Rosa J; Vanuga P; Payer J; Svobodník A
Vnitr Lek; 2008 Mar; 54(3):217-9, 221-4. PubMed ID: 18522288
[TBL] [Abstract][Full Text] [Related]
13. [Evaluation of the climacteric symptomatology modifications and clinical-instrumental parameters in women in physiological menopause treated with hormone replacement therapy with nomegestrol acetate and in surgical menopause treated with estrogen replacement therapy. Part I].
Savoca S; D'Agosta S; Lombardo G
Minerva Ginecol; 2007 Jun; 59(3):205-14. PubMed ID: 17576399
[TBL] [Abstract][Full Text] [Related]
14. Comparative cardiovascular effects of different progestins in menopause.
Rosano GM; Fini M
Int J Fertil Womens Med; 2001; 46(5):248-56. PubMed ID: 11720197
[TBL] [Abstract][Full Text] [Related]
15. Use of hormone replacement therapy in Washington State: is prevention being put into practice?
Saver BG; Taylor TR; Woods NF
J Fam Pract; 1999 May; 48(5):364-71. PubMed ID: 10334613
[TBL] [Abstract][Full Text] [Related]
16. Compliance to hormone replacement therapy.
Rozenberg S; Vandromme J; Kroll M; Pastijn A; Liebens F
Int J Fertil Menopausal Stud; 1995; 40 Suppl 1():23-32. PubMed ID: 7581586
[TBL] [Abstract][Full Text] [Related]
17. [Hormone therapy in climacteric. Different effects of estrogen and gestagen on the risk of breast and endometrial cancer].
Magnusson C; Weiderpass E
Lakartidningen; 2001 Jan; 98(5):418-21. PubMed ID: 11229082
[TBL] [Abstract][Full Text] [Related]
18. [Compliance with hormone replacement therapy].
Rozenberg S; Vandromme J; Kroll M; Twagirayezu P; Vyankandondera J
Rev Med Brux; 1995; 16(4):295-8. PubMed ID: 7481246
[TBL] [Abstract][Full Text] [Related]
19. Important factors for use of hormone replacement therapy: a population-based study of Swedish women. The Women's Health in Lund Area (WHILA) Study.
Li C; Samsioe G; Lidfelt J; Nerbrand C; Agardh CD;
Menopause; 2000; 7(4):273-81. PubMed ID: 10914621
[TBL] [Abstract][Full Text] [Related]
20. [Climacteric symptoms: intensity, incidence and need for treatment. A study of 716 women between 40 and 70 years of age].
Wenderlein JM; Clauder C
Zentralbl Gynakol; 1996; 118(11):598-604. PubMed ID: 9082692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
